What is the recommended aspirin dosing regimen and the rationale for selecting that dose?

Aspirin Dosing Recommendations

For secondary stroke prevention and most cardiovascular indications, aspirin 81 mg daily is the recommended maintenance dose, with a loading dose of 160-325 mg in acute settings.

Acute Stroke/TIA Setting

Loading Dose:

• 160 mg single loading dose after intracranial hemorrhage is excluded on neuroimaging 1
• Alternative loading doses of 160-325 mg are acceptable 2, 3
• Must be administered after dysphagia screening 2
• For patients receiving tPA, delay aspirin until 24-hour post-thrombolysis scan excludes hemorrhage 2

Special Acute Scenarios:

• Minor stroke (NIHSS ≤3) or high-risk TIA: Loading dose of 160-325 mg, then 81 mg daily with clopidogrel for 21 days 1
• Mild-moderate stroke (NIHSS ≤5): Loading dose of 300-325 mg, then 75-100 mg daily with ticagrelor for 30 days 1
• Dysphagia: Rectal aspirin 325 mg daily OR enteral tube aspirin 81 mg daily 1, 2

Long-Term Maintenance Dosing

Secondary Prevention (Post-Stroke/TIA):

• 81-325 mg daily for non-cardioembolic stroke 1
• The 2023 World Stroke Organization guidelines provide this range, but contemporary evidence strongly favors the lower end

Acute Coronary Syndromes:

• 81 mg daily maintenance is preferred over higher doses 4, 5, 3
• When used with ticagrelor specifically, 81 mg daily is mandatory 4, 3
• Initial loading: 162-325 mg 3

Coronary Artery Disease (Stable):

• 75-162 mg daily 6
• Post-CABG: 100-325 mg daily for 1 year 6

Peripheral Artery Disease:

• 75-325 mg daily 6

Evidence Strength and Rationale

The most recent and highest-quality evidence supports low-dose aspirin (75-100 mg daily) for maintenance therapy:

• The 2025 ACC/AHA ACS guidelines explicitly recommend 75-100 mg daily as the optimal maintenance dose 3
• The ADAPTABLE trial (2021) - the largest pragmatic trial with 15,076 patients - found no difference in cardiovascular events or major bleeding between 81 mg and 325 mg daily, but notably showed massive dose-switching from 325 mg to 81 mg (41.6% switched down) 7
• Multiple systematic reviews demonstrate that doses >75-81 mg provide no additional efficacy but increase gastrointestinal bleeding risk 8, 9

Key Pitfall: The 2023 World Stroke Organization guidelines cite a range of 81-325 mg 1, but this reflects consensus across diverse healthcare settings rather than optimal dosing. The evidence clearly favors the lower end of this range for maintenance therapy.

Diabetes-Specific Considerations

For patients with diabetes and established cardiovascular disease:

• 75-162 mg daily is optimal 10
• The 2025 Diabetes Care guidelines emphasize that this dose range provides maximal benefit with minimal bleeding risk 10

Primary Prevention (Controversial)

Not routinely recommended for most patients 11:

• May consider 75-100 mg daily in select adults 40-70 years at higher ASCVD risk without bleeding risk 11
• Contraindicated in adults >70 years for primary prevention 11
• Contraindicated in anyone at increased bleeding risk 11

Practical Algorithm

1. Acute stroke/TIA presentation:

   • Rule out hemorrhage on imaging
   • Screen for dysphagia
   • Give 160 mg loading dose (or 160-325 mg)
   • Continue 81 mg daily long-term

2. Acute coronary syndrome:

   • Give 162-325 mg loading dose
   • Continue 81 mg daily maintenance (mandatory if using ticagrelor)

3. Established cardiovascular disease:

   • Use 81 mg daily (or 75-100 mg daily per most recent guidelines)
   • Higher doses (325 mg) offer no additional benefit and increase bleeding

4. Special populations:

   • Dysphagia: Rectal 325 mg OR enteral 81 mg
   • Post-CABG: 100-325 mg for first year, then reduce to 81 mg
   • With dual antiplatelet therapy: Always use 81 mg aspirin component

The evidence overwhelmingly supports that once-daily low-dose aspirin (75-100 mg) achieves complete platelet thromboxane inhibition and provides maximal cardiovascular protection with minimal bleeding risk for long-term therapy.